Skip to content
healthcare.dev

DAPSONE

NDC 70954-135, Dapsone, tablet, from ANI Pharmaceuticals, Inc..

Product NDC
70954-135
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206505
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPSONE25 mg/1

Pharmacologic classes

Sulfone [EPC]; Sulfones [CS]

Package NDCNDC-11Package
70954-135-107095401351030 TABLET in 1 BOTTLE (70954-135-10)
70954-135-2070954013520100 TABLET in 1 BOTTLE (70954-135-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/57a47368-d1f6-4d61-a2ee-c5f1fe7ff690
  • NADAC price for package 70954013510

    GET /v1/drugs/nadac/70954013510
  • NADAC price for package 70954013520

    GET /v1/drugs/nadac/70954013520

Use it

Look up 70954-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.